Joseph Tung - 28 Feb 2025 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role
Director
Signature
/s/ Joseph Tung
Issuer symbol
SHPH
Transactions as of
28 Feb 2025
Net transactions value
$0
Form type
3
Filing time
21 Mar 2025, 20:00:06 UTC
Next filing
09 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SHPH COMMON STOCK 184,162 28 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The undersigned became a Reporting Person subject to Section 16 reporting on February 28, 2025. The Reporting Person received a grant of 184,162 restricted stock units ("RSUs") on March 5, 2025, which RSUs are subject to vesting over a period of three years, on February 28, 2026, February 28, 2027, and February 28, 2028.
F2 Consists of 184,162 RSUs, which remain subject to vesting.